A detailed history of Arvest Investments, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Arvest Investments, Inc. holds 16,421 shares of JNJ stock, worth $2.55 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
16,421
Previous 20,891 21.4%
Holding current value
$2.55 Million
Previous $3.05 Billion 12.84%
% of portfolio
0.4%
Previous 0.49%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$145.48 - $167.38 $650,295 - $748,188
-4,470 Reduced 21.4%
16,421 $2.66 Billion
Q2 2024

Aug 08, 2024

SELL
$144.38 - $157.78 $47,356 - $51,751
-328 Reduced 1.55%
20,891 $3.05 Billion
Q1 2024

Apr 19, 2024

SELL
$155.22 - $162.74 $876,993 - $919,481
-5,650 Reduced 21.03%
21,219 $3.36 Billion
Q4 2023

Jan 24, 2024

BUY
$145.6 - $158.88 $3.91 Million - $4.27 Million
26,869 New
26,869 $4.21 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Arvest Investments, Inc. Portfolio

Follow Arvest Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Arvest Investments, Inc. with notifications on news.